[Late phase II clinical study of irinotecan hydrochloride (CPT-11) in the treatment of malignant lymphoma and acute leukemia. The CPT-11 Research Group for Hematological Malignancies].

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples